KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Free Cash Flow: 2015-2025

Historic Free Cash Flow for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to $235.5 million.

  • Medpace Holdings' Free Cash Flow rose 69.99% to $235.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $676.8 million, marking a year-over-year increase of 26.35%. This contributed to the annual value of $572.3 million for FY2024, which is 44.25% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Free Cash Flow is $235.5 million, which was up 65.36% from $142.4 million recorded in Q2 2025.
  • Medpace Holdings' Free Cash Flow's 5-year high stood at $235.5 million during Q3 2025, with a 5-year trough of $37.0 million in Q1 2022.
  • Its 3-year average for Free Cash Flow is $133.0 million, with a median of $138.5 million in 2024.
  • In the last 5 years, Medpace Holdings' Free Cash Flow plummeted by 36.78% in 2021 and then surged by 108.58% in 2024.
  • Quarterly analysis of 5 years shows Medpace Holdings' Free Cash Flow stood at $61.8 million in 2021, then spiked by 106.29% to $127.4 million in 2022, then grew by 14.88% to $146.4 million in 2023, then climbed by 25.01% to $183.0 million in 2024, then surged by 69.99% to $235.5 million in 2025.
  • Its Free Cash Flow was $235.5 million in Q3 2025, compared to $142.4 million in Q2 2025 and $115.8 million in Q1 2025.